These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 24065476)
1. AKAP12/Gravin gene expression in colorectal cancer: clinical importance and review of the literature. Yildirim M; Suren D; Yildiz M; Sezgin Alikanoglu A; Eryilmaz R; Goktas S; Bulbuller N; Sezer C J BUON; 2013; 18(3):635-40. PubMed ID: 24065476 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of AKAP12 with HDAC3 depletion suppresses the progression and migration of colorectal cancer. He P; Li K; Li SB; Hu TT; Guan M; Sun FY; Liu WW Int J Oncol; 2018 Apr; 52(4):1305-1316. PubMed ID: 29484387 [TBL] [Abstract][Full Text] [Related]
3. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma. Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684 [TBL] [Abstract][Full Text] [Related]
4. Re-expression of AKAP12 inhibits progression and metastasis potential of colorectal carcinoma in vivo and in vitro. Liu W; Guan M; Hu T; Gu X; Lu Y PLoS One; 2011; 6(8):e24015. PubMed ID: 21918680 [TBL] [Abstract][Full Text] [Related]
5. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma. Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S Oncology; 2009; 77(1):53-62. PubMed ID: 19556810 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation. Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196 [TBL] [Abstract][Full Text] [Related]
7. Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis. Kitajima T; Toiyama Y; Tanaka K; Saigusa S; Kobayashi M; Inoue Y; Mohri Y; Kusunoki M Anticancer Res; 2014 Oct; 34(10):5321-9. PubMed ID: 25275025 [TBL] [Abstract][Full Text] [Related]
8. Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer. Karamitopoulou E; Zlobec I; Panayiotides I; Patsouris ES; Peros G; Rallis G; Lapas C; Karakitsos P; Terracciano LM; Lugli A Hum Pathol; 2011 Dec; 42(12):1888-96. PubMed ID: 21664646 [TBL] [Abstract][Full Text] [Related]
9. Lack of relation of AKAP12 with p53 and Bcl-2 in colorectal carcinoma. Suren D; Yildirim M; Alikanoglu AS; Kaya V; Yildiz M; Dilli UD; Sezer C Asian Pac J Cancer Prev; 2014; 15(8):3415-8. PubMed ID: 24870731 [TBL] [Abstract][Full Text] [Related]
10. Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer. Liu W; Guan M; Su B; Li J; Ma W; Liu C; Li M; Lin Y; Lu Y Clin Chim Acta; 2010 Jul; 411(13-14):940-6. PubMed ID: 20227403 [TBL] [Abstract][Full Text] [Related]
11. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer. Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314 [TBL] [Abstract][Full Text] [Related]
12. Expression of secretory leukocyte protease inhibitor detected by immunohistochemistry correlating with prognosis and metastasis in colorectal cancer. Liu G; Yang J; Zhao Y; Wang Z; Xing B; Wang L; Shi D World J Surg Oncol; 2014 Dec; 12():369. PubMed ID: 25441765 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of endothelial cell migration through the down‑regulation of MMP-9 by A-kinase anchoring protein 12. Lee SW; Jung KH; Jeong CH; Seo JH; Yoon DK; Suh JK; Kim KW; Kim WJ Mol Med Rep; 2011; 4(1):145-9. PubMed ID: 21461577 [TBL] [Abstract][Full Text] [Related]
15. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related]
16. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas. Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775 [TBL] [Abstract][Full Text] [Related]
17. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival. Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247 [TBL] [Abstract][Full Text] [Related]
18. Notch2 expression is decreased in colorectal cancer and related to tumor differentiation status. Chu D; Zheng J; Wang W; Zhao Q; Li Y; Li J; Xie H; Zhang H; Dong G; Xu C; Li M; Chen D; Ji G Ann Surg Oncol; 2009 Dec; 16(12):3259-66. PubMed ID: 19653042 [TBL] [Abstract][Full Text] [Related]
19. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342 [TBL] [Abstract][Full Text] [Related]
20. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67. Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]